CYP19A1 and breast cancer: Consequently, the key enzyme in estrogen synthesis, aromatase, invariably expressed in both cancerous and non-cancerous breast tissues, has been shown to be acetylated on several lysine residues in BC cells, in which the inhibition of SIRTs suppresses E2 biosynthesis but did not affect aromatase expression [8].